pI: 7.0572 |
Length (AA): 341 |
MW (Da): 37838 |
Paralog Number:
0
Signal peptide: N | GPI Anchor: N | Predicted trans-membrane segments: 0
Targets have been classified into druggability groups (DG) according to their druggability score in network driven prioritizations. DGs range from 1 to 5; the higher the group number, the higher the chance of the target to be druggable
Modbase 3D models:
There are 4 models calculated for this protein. More info on
these models, including the
models themselves is available at:
Modbase
Target Beg | Target End | Template | Template Beg | Template End | Identity | Evalue | Model Score | MPQS | zDope |
---|---|---|---|---|---|---|---|---|---|
1 | 341 | 1ek6 (A) | 1 | 344 | 51.00 | 0 | 1 | 1.6913 | -1.2 |
2 | 341 | 3enk (A) | 4 | 339 | 57.00 | 0 | 1 | 1.75637 | -1.38 |
4 | 340 | 5gy7 (A) | 2 | 335 | 52.00 | 0 | 1 | 1.71357 | -1.44 |
4 | 33 | 5f5n (A) | 7 | 36 | 43.00 | 0 | 0.63 | 0.534777 | 0.31 |
Help me make sense of these data.
A more detailed description of these scores is available at the Modbase Model Evaluation Help Pages, and in the papers referenced therein.
PDB Structures:
Upregulation Percent | Ranking | Stage | Dataset |
---|---|---|---|
Upper 80-100% percentile | Trophozoite, Rahman HM-1 IMSS Trophozoite. | Hon CC |
Hon CC | Transcriptomics of virulent and avirulent strains |
Ortholog group members (OG5_126853)
Species | Accession | Gene Product |
---|---|---|
Arabidopsis thaliana | AT4G20460 | putative UDP-arabinose 4-epimerase 3 |
Arabidopsis thaliana | AT1G63180 | UDP-glucose 4-epimerase |
Arabidopsis thaliana | AT5G44480 | putative UDP-arabinose 4-epimerase 4 |
Arabidopsis thaliana | AT4G10960 | UDP-glucose 4-epimerase 5 |
Arabidopsis thaliana | AT1G64440 | UDP-glucose 4-epimerase |
Arabidopsis thaliana | AT1G30620 | UDP-arabinose 4-epimerase 1 |
Arabidopsis thaliana | AT1G12780 | bifunctional UDP-glucose 4-epimerase and UDP-xylose 4-epimerase 1 |
Arabidopsis thaliana | AT3G28530 | UDP-glucose 4-epimerase |
Arabidopsis thaliana | AT4G23920 | UDP-glucose 4-epimerase 2 |
Brugia malayi | Bm1_55785 | UDP galactose 4'-epimerase |
Candida albicans | CaO19.11156 | likely UDP glucose-4-epimerase similar to S. pombe SPBPB2B2.12c and to S. cerevisiae GAL10 (YBR019C) involved in galactose metab |
Candida albicans | CaO19.3672 | likely UDP glucose-4-epimerase similar to S. pombe SPBPB2B2.12c and to S. cerevisiae GAL10 (YBR019C) involved in galactose metab |
Caenorhabditis elegans | CELE_C47B2.6 | Protein GALE-1, isoform B |
Cryptosporidium hominis | Chro.40292 | UDP-glucose 4-epimerase |
Cryptosporidium parvum | cgd4_2600 | UDP-glucose 4-epimerase |
Dictyostelium discoideum | DDB_G0275295 | UDP-glucose 4-epimerase |
Drosophila melanogaster | Dmel_CG12030 | UDP-galactose 4'-epimerase |
Escherichia coli | b0759 | UDP-galactose-4-epimerase |
Echinococcus granulosus | EgrG_000984800 | UDP glucose 4 epimerase |
Entamoeba histolytica | EHI_192050 | UDP-glucose 4-epimerase, putative |
Echinococcus multilocularis | EmuJ_000984800 | UDP glucose 4 epimerase |
Giardia lamblia | GL50803_7982 | UDP-glucose 4-epimerase |
Homo sapiens | ENSG00000117308 | UDP-galactose-4-epimerase |
Leishmania braziliensis | LbrM.33.2590 | udp-glc 4-epimerase, putative |
Leishmania donovani | LdBPK_332430.1 | udp-glc 4'-epimerase, putative |
Leishmania infantum | LinJ.33.2430 | udp-glc 4-epimerase, putative |
Leishmania major | LmjF.33.2300 | udp-glc 4-epimerase, putative |
Leishmania mexicana | LmxM.32.2300 | udp-glc 4-epimerase, putative |
Loa Loa (eye worm) | LOAG_00131 | UDP galactose 4'-epimerase |
Mus musculus | ENSMUSG00000028671 | galactose-4-epimerase, UDP |
Neospora caninum | NCLIV_046950 | UDP-glucose 4-epimerase (EC 5.1.3.2), related |
Oryza sativa | 4345415 | Os08g0374800 |
Oryza sativa | 4337011 | Os04g0618200 |
Oryza sativa | 4339812 | Os05g0595100 |
Oryza sativa | 4347638 | Os09g0526700 |
Oryza sativa | 4346723 | Os09g0323000 |
Oryza sativa | 4344584 | Os08g0129700 |
Oryza sativa | 4342364 | Os07g0139400 |
Saccharomyces cerevisiae | YBR019C | bifunctional UDP-glucose 4-epimerase/aldose 1-epimerase |
Schistosoma japonicum | Sjp_0303190 | ko:K01784 UDP-glucose 4-epimerase [EC5.1.3.2], putative |
Schistosoma mansoni | Smp_070780 | UDP-glucose 4-epimerase |
Schmidtea mediterranea | mk4.011065.00 | UDP-glucose 4-epimerase |
Schmidtea mediterranea | mk4.008355.00 | |
Trypanosoma brucei gambiense | Tbg972.11.3030 | UDP-galactose 4-epimerase, putative |
Trypanosoma brucei | Tb927.11.2730 | UDP-galactose 4-epimerase |
Trypanosoma congolense | TcIL3000_0_38310 | UDP-galactose 4-epimerase |
Trypanosoma cruzi | TcCLB.506303.50 | UDP-galactose 4-epimerase, putative |
Trypanosoma cruzi | TcCLB.506811.190 | UDP-galactose 4-epimerase |
Toxoplasma gondii | TGME49_225880 | UDP-glucose 4-epimerase |
Trichomonas vaginalis | TVAG_058150 | NAD dependent epimerase/dehydratase, putative |
Trichomonas vaginalis | TVAG_101620 | NAD dependent epimerase/dehydratase, putative |
Trichomonas vaginalis | TVAG_186740 | UDP-glucose 4-epimerase, putative |
Gene/Ortholog | Organism | Phenotype | Source Study |
---|---|---|---|
Tb11.02.0330 | Trypanosoma brucei | no significant loss or gain of fitness in bloodstream forms (3 days) | alsford |
Tb11.02.0330 | Trypanosoma brucei | significant gain of fitness in bloodstream forms (6 days) | alsford |
Tb11.02.0330 | Trypanosoma brucei | no significant loss or gain of fitness in procyclic forms | alsford |
Tb11.02.0330 | Trypanosoma brucei | significant gain of fitness in differentiation of procyclic to bloodstream forms | alsford |
b0759 | Escherichia coli | non-essential | goodall |
TGME49_225880 | Toxoplasma gondii | Probably non-essential | sidik |
nmpdr | Genome-scale essentiality datasets from published studies (M. tuberculosis) | National Microbial Pathogen Data Resource |
gerdes | Experimental determination and system-level analysis of essential genes in E. coli MG1655 | Gerdes et al., J Bacteriol. 2003 185:5673-84 |
alsford | High-throughput phenotyping using parallel sequencing of RNA interference targets in the African trypanosome | Genome Res 2011, 21:915-924 |
yeastgenome | Systematic deletion of yeast genes | Saccharomyces Genome Database |
shigen | Profiling of E. coli Chromosome (PEC) | National Institute of Genetics, Japan |
blattner | Systematic mutagenesis of the E. coli (MG1655) genome | J Bacteriol 2004, 186:4921-4930 |
wormbase | C. elegans RNAi experiments | WormBase web site, http://www.wormbase.org, release WS170 |
keio | Systematic single-gene knock-out mutants of E. coli K12 | The Keio Collection |
neb | C. elegans RNAi phenotypes | Data obtained from Wormbase WS150, curated by K. Chaudary and T. Carlow, New England Biolabs |
In TDR Targets, information about phenotypes that are caused by drugs, or by genetic manipulation of cells (e.g. gene knockouts or knockdowns) is manually curated from the literature. These descriptions help to describe the potential of the target for drug development. If no information is available for this gene or if the information is incomplete, this may mean that i) the papers containing this information either appeared after the curation effort for this organism was carried out or they were inadvertently missed by curators; or that ii) the curation effort for this organism has not yet started.
In any case, if you have information about papers containing relevant validation data for this target, please contact us.
Species | Known druggable target | Linked compounds | Reference |
---|---|---|---|
Homo sapiens | UDP-galactose-4-epimerase | Compounds | References |
Trypanosoma brucei gambiense | UDP-galactose 4-epimerase, putative | Compounds | References |
Trypanosoma brucei | UDP-galactose 4-epimerase | Compounds | References |